Earnings ·
Bausch Health Companies Inc. reported second quarter 2026 results with consolidated revenues of $2.85 billion, a 13%…
BHCBausch Health Companies Inc.
Bausch Health Companies Inc. reported second quarter 2026 results with consolidated revenues of $2.85 billion, a 13% increase from the prior year period. GAAP net income attributable to Bausch Health was $258 million, or $0.68 per diluted share, compared to $148 million and $0.40 per share in the previous year. Adjusted EBITDA reached $1,075 million, up 28% from the prior year. The company raised its full-year 2026 guidance for revenue to between $10.79 billion and $11.04 billion and adjusted EBITDA to between $4.05 billion and $4.175 billion. Bausch Health operates as a global diversified pharmaceutical and eye health company.